Showing results (221-230 of 335) with videos related to
Sort By:
Pageof 34
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based studySusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 15, 2014
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery diseaseLisanne C de Vos, Douwe J Mulder, Andries J Smit, et al.European Heart Journal|April 6, 2007
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglyceridesSusanna E Borggreve, Hans L Hillege, Geesje M Dallinga-Thie, et al.European Journal of Clinical Investigation|July 10, 2025
Branched-chain amino acids and all-cause mortality in patients with liver cirrhosis, and the onset of diabetes in liver transplant recipientsYakun Li, Mateo Chvatal-Medina, Maria Camila Trillos-Almanza, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 7, 2004
Lack of radiation optic neuropathy in 72 patients treated for pituitary adenomaAlfons C M van den Bergh, Michiel A Schoorl, Robin P F Dullaart, et al.The Journal of Clinical Endocrinology and Metabolism|April 21, 2005
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglyceridesSusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.Frontiers in Genetics|January 20, 2022
Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic EmiratesAntoine Rimbert, Hinda Daggag, Peter Lansberg, et al.European Journal of Clinical Investigation|March 22, 2016
Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCTJorien Werumeus Buning, Jenny E Kootstra-Ros, Pauline Brummelman, et al.Cardiovascular Diabetology|May 15, 2026
Drug targets for lipid modification and risk of type 2 diabetes: a cis-Mendelian randomization studyZekai Chen, Rima D Triatin, Li Luo, et al.Thrombosis and Haemostasis|September 8, 2012
Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort studyInge M van Schouwenburg, Bakhtawar K Mahmoodi, Ron T Gansevoort, et al.Pageof 34